These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23682730)

  • 21. Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods.
    Huete-Pérez JA; Flores-Obando RE; Ghedin E; Caffrey CR
    Expert Rev Mol Diagn; 2005 Jul; 5(4):521-30. PubMed ID: 16013970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The suppression of galactose metabolism in Trypanosoma cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphology.
    MacRae JI; Obado SO; Turnock DC; Roper JR; Kierans M; Kelly JM; Ferguson MA
    Mol Biochem Parasitol; 2006 May; 147(1):126-36. PubMed ID: 16569451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis.
    Parodi-Talice A; Monteiro-Goes V; Arrambide N; Avila AR; Duran R; Correa A; Dallagiovanna B; Cayota A; Krieger M; Goldenberg S; Robello C
    J Mass Spectrom; 2007 Nov; 42(11):1422-32. PubMed ID: 17960573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library.
    Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO
    Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exoproteome profiling of Trypanosoma cruzi during amastigogenesis early stages.
    Mandacaru SC; Queiroz RML; Alborghetti MR; de Oliveira LS; de Lima CMR; Bastos IMD; Santana JM; Roepstorff P; Ricart CAO; Charneau S
    PLoS One; 2019; 14(11):e0225386. PubMed ID: 31756194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of the plasma membrane subproteome of bloodstream form Trypanosoma brucei.
    Bridges DJ; Pitt AR; Hanrahan O; Brennan K; Voorheis HP; Herzyk P; de Koning HP; Burchmore RJ
    Proteomics; 2008 Jan; 8(1):83-99. PubMed ID: 18095354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
    Campos MA; Gazzinelli RT
    Mediators Inflamm; 2004 Jun; 13(3):139-43. PubMed ID: 15223603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis of the human pathogen Trypanosoma cruzi.
    Paba J; Santana JM; Teixeira AR; Fontes W; Sousa MV; Ricart CA
    Proteomics; 2004 Apr; 4(4):1052-9. PubMed ID: 15048986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
    Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
    J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface capturing technologies for the surfaceome discovery of hepatocytes.
    Bausch-Fluck D; Hofmann A; Wollscheid B
    Methods Mol Biol; 2012; 909():1-16. PubMed ID: 22903705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and preliminary characterization of a putative C-type lectin receptor-like protein in the T. cruzi tomato lectin endocytic-enriched proteome.
    Brosson S; Bottu G; Pays E; Bousbata S; Salmon D
    Microbiol Res; 2017 Dec; 205():73-79. PubMed ID: 28942847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease.
    Gruber A; Zingales B
    Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.
    Cestari I; Ansa-Addo E; Deolindo P; Inal JM; Ramirez MI
    J Immunol; 2012 Feb; 188(4):1942-52. PubMed ID: 22262654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological characterization of potassium conductive pathways in Trypanosoma cruzi.
    Jimenez V; Henriquez M; Galanti N; Riquelme G
    J Cell Biochem; 2011 Apr; 112(4):1093-102. PubMed ID: 21308738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma membrane ATP receptors in Trypanosoma cruzi trypomastigotes.
    Inverso JA; Song Y; Santos-Buch CA
    Receptor; 1995; 5(4):197-206. PubMed ID: 8840398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphoproteomic analysis of the human pathogen Trypanosoma cruzi at the epimastigote stage.
    Nakayasu ES; Gaynor MR; Sobreira TJ; Ross JA; Almeida IC
    Proteomics; 2009 Jul; 9(13):3489-506. PubMed ID: 19579231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B; Garcia CR
    Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Trypanosoma cruzi proteome.
    Atwood JA; Weatherly DB; Minning TA; Bundy B; Cavola C; Opperdoes FR; Orlando R; Tarleton RL
    Science; 2005 Jul; 309(5733):473-6. PubMed ID: 16020736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma cruzi: circulating polysaccharide factors excreted in vitro and in vivo.
    Martín UO; Afchain D; Loyens M; Maidana C; Caprón A
    Medicina (B Aires); 1989; 49(1):33-6. PubMed ID: 2517138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.